Condition: Atrial Fibrillation (AF) · Sponsor: Vektor Medical
The goal of this clinical trial is to compare the use of the Vektor Computational ECG Mapping System (vMap®) with pulmonary vein isolation (PVI), to using PVI alone, to treat Atrial Fibrillation (AF) in adults. Participants will have a 50/50 or 1 out of 2 chance of being placed in the treatment or control arm. The control arm of the study involves PVI alone for ablation procedure(s). The treatment arm involves the use of vMap mapping in addition to PVI to plan ablation procedure(s).
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Arrhythmia Research Group - St. Bernards | Jonesboro, Arkansas, United States | Recruiting |
| BayCare Health System | Clearwater, Florida, United States | Recruiting |
| Baptist Health Jacksonville | Jacksonville, Florida, United States | Recruiting |
| USF Health | Tampa, Florida, United States | Recruiting |
| Piedmont Heart of Athens | Athens, Georgia, United States | Not Yet Recruiting |
| Piedmont Heart Institute | Atlanta, Georgia, United States | Recruiting |
| Indiana University | Indianapolis, Indiana, United States | Recruiting |
| Baptist Health Lexignton | Lexington, Kentucky, United States | Recruiting |
| Westchester Medical Center | Valhalla, New York, United States | Recruiting |
| OhioHealth | Columbus, Ohio, United States | Recruiting |
| University of Toledo Medical Center | Toledo, Ohio, United States | Not Yet Recruiting |
| Penn Presbyterian | Philadelphia, Pennsylvania, United States | Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06935591